Clinical Trials Browser

OTHER × Urologic Neoplasms × Fatty Acids, Omega-3 × Clear all

NCT03204266 2022-08-24

Oral Supplementation to Enhance Recovery Pilot Study

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms, Urologic Neoplasms